MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Short-term investments, atamortized cost$92,297K Cash and cashequivalents$14,557K Inventory$7,631K Accounts receivable, net$4,246K Prepaid expenses andother current assets$4,206K Total current assets$122,937K Investments, non-current, atamortized cost$40,811K Property and equipment,net$16,637K Right-of-use asset -operating leases$10,699K Other assets$2,606K Intangible assets, net$783K Total assets$194,473K Total liabilities andstockholders' equity$194,473K Total stockholders'equity$167,886K Total liabilities$26,587K Accumulated deficit-$266,233K Additional paid-in capital$433,048K Operating leaseliability, net of current...$16,113K Total currentliabilities$10,212K Other liabilities$262K Common stock, 0.01 parvalue 400,000,000...$1,071K Accrued expenses andother$4,371K Deferred revenue,current portion$3,271K Operating leaseliability, current$1,374K Accounts payable$1,196K
Balance Sheet
source: myfinsight.com

MAXCYTE, INC. (MXCT)

MAXCYTE, INC. (MXCT)